The rs1550117 A>G variant in DNMT3A gene promoter significantly increases non-small cell lung cancer susceptibility

Serum detection of epidermal growth factor receptor gene mutations using mutant-enriched sequencing in Chinese patients with advanced non-small cell lung cancer.. Comparison of

non-small cell lung cancer A549 cells using an adenovirus vector containing the human sodium iodide symporter (NIS) gene driven by the survivin promoter.. The recombinant

ALK FISH Assays for Non-small Cell Lung Cancer Treatment Selection: Scoring Issues and Probe Design – Lawce and Olson variant 1 variant 2 variant 3a variant 3b variant 4a variant

Prognostic significance of DAPK and RASSF1A promoter hypermethylation in non-small cell lung cancer (NSCLC).

Clinical benefit from EGFR-TKI plus ginsenoside Rg3 in patients with advanced non-small cell lung cancer harboring EGFR active mutation.. Yan Li 1,* , Yanmei Wang 1,* , Kai Niu 1

miR-26a and miR-214 down-regulate expression of the PTEN gene in chronic lymphocytic leukemia, but not PTEN mutation or promoter methylation.. Zhi-Jian Zou 1,2 , Lei Fan 1 , Li Wang

Concurrent gene alterations with EGFR mutation and treatment efficacy of EGFR-TKIs in Chinese patients with non-small cell lung cancer.. Wentao Hu 1 , Yahui Liu 2 , Jian

The role of metabolic tumor volume (MTV) measured by [18F] FDG PET/CT in predicting EGFR gene mutation status in non- small cell lung cancer.. Ao Liu 1,2 , Anqin Han 2 , Hui Zhu 2 ,